A blood atlas of COVID-19 defines hallmarks of disease severity and specificityDavid Ahern, Hal Drakesmith, Dominik Aschenbrenner et al.|Cell|2022Cited by 327
High-throughput mass spectrometry maps the sepsis plasma proteome and differences in patient responseYuxin Mi, Marie McCauley, Katie L. Burnham et al.|Science Translational Medicine|2024Cited by 55
A blood atlas of COVID-19 defines hallmarks of disease severity and specificityDavid Ahern, Susanna Dunachie, Zhichao Ai et al.|medRxiv|2021Cited by 35
High-throughput mass spectrometry maps the sepsis plasma proteome and differences in responseYuxin Mi, Julian C. Knight, Katie L. Burnham et al.|medRxiv|2022Cited by 5